FIELD: medicine.
SUBSTANCE: invention relates to the use of trihydrochloride of N1-(2,3,4-trimethoxybenzyl)-N2-{2-[(2,3,4-trimethoxybenzyl)amino]ethyl}-1,2-ethanediamine, which has a cardiotropic effect, as an analgesic and anxiolytic agent.
EFFECT: obtaining a cardiotropic agent with anxiolytic and analgesic properties.
1 cl, 4 ex, 3 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
ORGANIC SALTS N1-(2,3,4-TRIMETHOXYBENZYL)-N2-{2-[(2,3,4-TRIMETHOXYBENZYL)AMINO]ETHYL}-1,2-ETHANE-DIAMINE | 2022 |
|
RU2813347C2 |
LOW MOLECULAR WEIGHT MIMETIC OF BRAIN NEUROTROPHIC FACTOR WITH ANALGESIC, ANXIOLYTIC AND ANTIADDICTIVE EFFECTS | 2020 |
|
RU2759023C2 |
SUBSTANCE RESTORING PHYSICAL PERFORMANCE AFTER ACUTE FATIGUE | 2021 |
|
RU2784542C2 |
BIS(ALKOXYBENZYL)ALKANDIAMINES WITH CARDIOTROPICACTIVITY | 2021 |
|
RU2791576C2 |
BIS(METOXYBENZYLAMINOALKYL)AMINES WITH CARDIOTROPIC ACTIVITY | 2014 |
|
RU2624438C2 |
AGENT FOR MANAGING ALCOHOL ABSTINENCE SYNDROME | 2012 |
|
RU2521226C2 |
2-BENZYL DERIVATIVE OF 4-(3H)QUINAZOLINONE, HAVING ANALGESIC, ANTI-PARKINSONIAN, ANTIHYPOXANT, TRANQUILISING ACTION | 2019 |
|
RU2715884C1 |
SUBSTITUTED 1,2,5-TRIMETHYL- AND 2,2,6,6-TETRAMETHYL-4-AMINOPIPERIDINES, HAVING ANTI-ISCHEMIC ACTIVITY | 2015 |
|
RU2686317C2 |
1-(METHOXYBENZYL)-4-[2-((METHOXYBENZYL)AMINO)ETHYL]PIPERAZINES, WHICH HAVE ANTIARRHYTHMIC ACTIVITY | 2018 |
|
RU2751878C2 |
QUINAZOLIN-4(3H)-ONE DIMETHOXYBENZYLSULFO DERIVATIVE WITH ANALGESIC, ANTIPARKINSONIAN, ANXIOLYTIC, PSYCHOSTIMULATING ACTIVITY | 2021 |
|
RU2758333C1 |
Authors
Dates
2022-05-30—Published
2020-07-06—Filed